Zinc and Immune Outcomes: What the Trial Evidence Reports

Zinc is classified as an essential trace mineral, and it is deeply integrated into immune architecture. More than 300 metalloenzymes require zinc as a structural or catalytic cofactor, and around 2,000 transcription factors depend on zinc-finger motifs for DNA binding. Immune cells — particularly lymphocytes, monocytes, and neutrophils — concentrate zinc at levels substantially higher than surrounding plasma, which reflects the metal's functional importance in immune signalling. **Thymulin and T-cell maturation** Thymulin is a thymic peptide that promotes the differentiation and maturation of T lymphocytes. It is biologically active only when zinc is bound to it. Studies in zinc-deficient animal models showed thymulin activity fell to near-zero levels, with corresponding losses in T-helper and cytotoxic T-cell populations. Human studies in zinc-deficient elderly individuals found that six months of zinc supplementation restored thymulin activity and normalised CD4+/CD8+ T-cell ratios. Prasad et al. reported these effects in a series of mechanistic studies in the 1990s and early 2000s (PMID: 8875519). **Neutrophil oxidative burst** Neutrophils are a first-line innate immune defence. On encountering a pathogen, they generate reactive oxygen species (ROS) — the oxidative burst — to destroy invading microorganisms. Zinc is required for the activity of NADPH oxidase, the enzyme that drives this burst. Studies of zinc-deficient children in developing countries found significantly impaired neutrophil killing capacity that was partly reversed by supplementation. A mechanistic review in the Journal of Nutritional Biochemistry documented that zinc depletion reduced NADPH oxidase assembly at the plasma membrane, directly impairing burst activity (PMID: 26506350). **Natural killer cell cytotoxicity and cytokine regulation** Natural killer (NK) cells provide immediate innate immune surveillance against viral-infected cells. Zinc deficiency has been consistently associated with reduced NK cell cytotoxicity in both animal and human studies. Mechanistically, zinc modulates signal transduction via protein kinase C and influences the production of pro-inflammatory cytokines including TNF-α, IL-1β, and IL-6. Notably, zinc also suppresses NF-κB signalling at adequate concentrations — providing a dual role as both an immune activator and an anti-inflammatory signal at physiological levels. A comprehensive mechanistic review by Wessells and Brown (2012) in PLOS ONE mapped these pathways across the major immune cell lineages (PMID: 22629421). **Zinc and the innate antiviral response** Zinc ions have demonstrated direct antiviral activity in vitro. Intracellular zinc inhibits RNA-dependent RNA polymerase activity — the enzyme used by many RNA viruses (including rhinoviruses and coronaviruses) to replicate. Ionophore compounds (such as quercetin and hydroxychloroquine in experimental settings) can enhance zinc entry into cells, amplifying this effect. This mechanism is relevant to understanding both the common cold lozenge literature and the COVID-19 trial data discussed in subsequent sections. The sum of mechanistic evidence positions zinc as a genuinely multi-functional immune nutrient — operating across innate phagocytic killing, adaptive T-cell differentiation, NK cell cytotoxicity, cytokine modulation, and direct antiviral activity. This breadth underpins the EFSA-authorised health claim for zinc's contribution to the normal function of the immune system.